OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
28 hedge funds and large institutions have $6.09M invested in OncoSec Medical Incorporated in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
15% more capital invested
Capital invested by funds: $5.31M → $6.09M (+$775K)
18% less funds holding
Funds holding: 34 → 28 (-6)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$321K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.63K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.85K |
| 5 |
VF
Virtu Financial
New York
|
+$4.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$213K |
| 2 |
Renaissance Technologies
New York
|
-$192K |
| 3 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$72K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$34K |
| 5 |
SFP
Sandbox Financial Partners
Bethesda,
Maryland
|
-$33.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | +$169 | +8 | +114% |
|
|
27
Two Sigma Advisers
New York
| – | -$213K | -10,071 | Closed |
|
|
NAM
28
Nexpoint Asset Management
Dallas,
Texas
| – | -$72K | -3,409 | Closed |
|
|
TSS
29
Two Sigma Securities
New York
| – | -$34K | -1,594 | Closed |
|
30
Two Sigma Investments
New York
| – | -$10K | -473 | Closed |
|
31
Simplex Trading
Chicago,
Illinois
| – | -$464 | -22 | Closed |
|
ONCS Hedge Fund Activity: Q1 2022 in Review
28 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2022, worth a combined $6.09M — up 15% from $5.31M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ONCS and 1 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Bank of New York Mellon, adding an estimated $321K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $213K sold.
- 28 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2022, down from 34 in Q4 2021.
- Funds reported $6.09M of OncoSec Medical Incorporated stock for Q1 2022, up 15% quarter-over-quarter.
- 1 fund opened new OncoSec Medical Incorporated positions in Q1 2022 and 7 closed out, a net change of -6 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2022 was Bank of New York Mellon, an estimated $321K added.
- The largest OncoSec Medical Incorporated seller in Q1 2022 was Two Sigma Advisers, an estimated $213K sold.
Based on aggregated 13F filings for Q1 2022.